Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


46th World Congress on Microbiology

Dublin, Ireland

Stef Stienstra

Stef Stienstra

Scientific Advisor Royal Dutch Navy, Netherlands


Stef Stienstra is a Strategic and Creative Development Manager in Biomedical Science, who works internationally for several medical and biotech companies as Scientific Advisory Board Member. He is also an active Reserve-Officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces, he is CBRNe specialist with focus on (micro)biological and chemical threats. He is also Manager of the group of medical- and environmental functional specialists within the 1st CMI (Civil Military Interaction) Battalion of the Dutch Armed Forces. In his civilian position, he is at this moment developing with MT-Derm in Berlin (Germany), a novel interdermal vaccination technology as well as a new therapy for cutaneous leishmaniasis for which he has won a Canadian ‘Grand Challenge’ grant. With Hemanua in Dublin (Ireland), he has developed an innovative blood separation unit, which is also suitable to produce convalescent plasma for Ebola Virus Disease therapy. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a Doctorate and has extensive practical experience in cell biology, immuno-haematology, infectous diseaases, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often generated from unexpected combinations of technologies. He consults at top level management, in which his good understanding of abstract science combined with excellent skills in communication of scientific matters to non-specialists helps to get things done.


Abstract : The threat mitigation of emerging infectious diseases globally